戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 tibody escape data from horses infected with equine infectious anemia virus.
2                    Ponies were infected with equine infectious anemia virus.
3 g the properties of the LYPDL late domain of equine infectious anemia virus.
4 y against N-tropic murine leukemia virus and equine infectious anemia virus.
5 during experimental infection of ponies with equine infectious anemia virus.
6 sease in ponies experimentally infected with equine infectious anemia virus.
7 transcriptases of human immunodeficiency and equine infectious anemia viruses.
8 Previous pre-steady-state kinetic studies of equine infectious anemia virus-1 (EIAV) reverse transcri
9     The human immunodeficiency virus type 1, equine infectious anemia virus, and adenovirus L1 3' pro
10 CDs of HIV-2, bovine immunodeficiency virus, equine infectious anemia virus, and feline immunodeficie
11                          Foals infected with equine infectious anemia virus become thrombocytopenic 7
12 oma virus (contained in its p2b sequence) or equine infectious anemia virus (contained in p9).
13  the prototype YPDL-type L domain encoded by equine infectious anemia virus (EIAV) acts by recruiting
14 atypical NES-containing Rev-like proteins of equine infectious anemia virus (EIAV) and feline immunod
15       Human immunodeficiency virus (HIV) and equine infectious anemia virus (EIAV) are closely relate
16                Permeabilized preparations of equine infectious anemia virus (EIAV) are shown here to
17           This study, using CA proteins from equine infectious anemia virus (EIAV) as an example, dem
18 ruses is disrupted by proteasome inhibitors, equine infectious anemia virus (EIAV) budding is not aff
19                            A novel strain of equine infectious anemia virus (EIAV) called vMA-1c that
20  immunodeficiency virus type one (HIV-1) and equine infectious anemia virus (EIAV) capsid proteins, a
21                        Since the L domain of equine infectious anemia virus (EIAV) contains a Yxxthet
22                                              Equine infectious anemia virus (EIAV) contains the simpl
23 repeat (LTR) of macrophage-tropic strains of equine infectious anemia virus (EIAV) contains three PU.
24 molecular clones pSPeiav19 and p19/wenv17 of equine infectious anemia virus (EIAV) differ in env and
25  current study examined the entry pathway of equine infectious anemia virus (EIAV) during infection o
26                               The lentivirus equine infectious anemia virus (EIAV) encodes the small
27 thesis directly, we examined the patterns of equine infectious anemia virus (EIAV) envelope variation
28             Here we show that the budding of equine infectious anemia virus (EIAV) from infected equi
29 ssays with transfected cells reveal that the equine infectious anemia virus (EIAV) Gag p9 protein pro
30                          While activation of equine infectious anemia virus (EIAV) gene expression by
31 f three functionally distinct regions of the equine infectious anemia virus (EIAV) genome (env, rev,
32 1), feline immunodeficiency virus (FIV), and equine infectious anemia virus (EIAV) genomic RNA.
33 sly that a lentiviral vector system based on equine infectious anemia virus (EIAV) gives rise to high
34 t (LTR) sequence variation of the lentivirus equine infectious anemia virus (EIAV) has not been explo
35                       The entry mechanism of equine infectious anemia virus (EIAV) has yet to be exam
36 recombinant p26 capsid protein (CA) from the equine infectious anemia virus (EIAV) have in common an
37 share common assembly mechanisms, studies of equine infectious anemia virus (EIAV) have indicated alt
38 whole-virus and envelope subunit vaccines to equine infectious anemia virus (EIAV) have revealed a br
39                                              Equine infectious anemia virus (EIAV) infection of horse
40                                              Equine infectious anemia virus (EIAV) infection of horse
41 f N-tropic murine leukemia virus (N-MLV) and equine infectious anemia virus (EIAV) infection, promoti
42                               The control of equine infectious anemia virus (EIAV) infections of hors
43 tudies have demonstrated that the lentivirus equine infectious anemia virus (EIAV) infects tissue mac
44                Entry of wild-type lentivirus equine infectious anemia virus (EIAV) into cells require
45                                              Equine infectious anemia virus (EIAV) is a lentivirus th
46                                              Equine infectious anemia virus (EIAV) is a lentivirus wi
47            In contrast, the YPDL L domain of equine infectious anemia virus (EIAV) is apparently uniq
48 usly demonstrated that the Gag p9 protein of equine infectious anemia virus (EIAV) is functionally ho
49                                              Equine infectious anemia virus (EIAV) is genetically one
50            Persistent infection of equids by equine infectious anemia virus (EIAV) is typically chara
51                                              Equine infectious anemia virus (EIAV) is unique among en
52 an immunodeficiency virus type 1 (HIV-1) and equine infectious anemia virus (EIAV) L domain-derived p
53 e have identified an interaction between the equine infectious anemia virus (EIAV) late assembly doma
54 n for human immunodeficiency virus (HIV) and equine infectious anemia virus (EIAV) lentiviral vectors
55                                    Using the equine infectious anemia virus (EIAV) lentivirus model s
56 gomerization of the naturally unmyristylated equine infectious anemia virus (EIAV) MA and its interac
57 asma from a horse persistently infected with equine infectious anemia virus (EIAV) neutralized homolo
58                                          The equine infectious anemia virus (EIAV) often results in l
59                                  We examined equine infectious anemia virus (EIAV) particles and foun
60 image human immunodeficiency virus (HIV) and equine infectious anemia virus (EIAV) particles.
61                         Wild-type strains of equine infectious anemia virus (EIAV) prevent superinfec
62                                              Equine infectious anemia virus (EIAV) provides a natural
63                                              Equine infectious anemia virus (EIAV) provides a uniquel
64 ncy virus (BIV), maedi-visna virus (MVV) and equine infectious anemia virus (EIAV) readily interacted
65 brain and another data set consisting of the equine infectious anemia virus (EIAV) regulatory gene re
66                                              Equine infectious anemia virus (EIAV) Rev is an essentia
67  export of incompletely spliced viral mRNAs, equine infectious anemia virus (EIAV) Rev regulates alte
68  significant variation in the second exon of equine infectious anemia virus (EIAV) rev.
69 t serial truncation of the Gag p9 protein of equine infectious anemia virus (EIAV) revealed a progres
70                              Two variants of equine infectious anemia virus (EIAV) that differed in s
71 mmunodeficiency virus mac239 (SIVmac239) and equine infectious anemia virus (EIAV) the most dependent
72            We employed the equine lentivirus equine infectious anemia virus (EIAV) to investigate the
73                      All lentiviruses except equine infectious anemia virus (EIAV) use the small acce
74 in budding assays that the Gag p9 protein of equine infectious anemia virus (EIAV) utilizes a unique
75                A highly effective attenuated equine infectious anemia virus (EIAV) vaccine (EIAV(D9))
76 s nonpathogenic molecular clone (19-2-6A) of equine infectious anemia virus (EIAV) was modified by su
77 g the Gag/Pr or SU protein of the lentivirus equine infectious anemia virus (EIAV) were constructed a
78 n we studied the full-length CA protein from equine infectious anemia virus (EIAV), a lentivirus shar
79                                              Equine infectious anemia virus (EIAV), a macrophage-trop
80  efficacious subunit peptide vaccine against equine infectious anemia virus (EIAV), a naturally occur
81            A Tyr-Pro-Asp-Leu (YPDL) motif in equine infectious anemia virus (EIAV), and a related seq
82 an immunodeficiency virus type 1 (HIV-1) and equine infectious anemia virus (EIAV), and inhibits the
83  an experimental live attenuated vaccine for equine infectious anemia virus (EIAV), based on mutation
84               Human cells restrict N-MLV and equine infectious anemia virus (EIAV), but not HIV-1, HI
85 iruses, the ungulate lentiviruses, including equine infectious anemia virus (EIAV), exclusively infec
86  (SIV), bovine immunodeficiency virus (BIV), equine infectious anemia virus (EIAV), feline immunodefi
87 Control of a naturally occurring lentivirus, equine infectious anemia virus (EIAV), occurs in most in
88  HIV-1, feline immunodeficiency virus (FIV), equine infectious anemia virus (EIAV), or N-tropic murin
89                                              Equine infectious anemia virus (EIAV), uniquely among le
90                                        Using equine infectious anemia virus (EIAV), we now demonstrat
91                                StarGen is an equine infectious anemia virus (EIAV)-based lentiviral v
92                                         Most equine infectious anemia virus (EIAV)-infected horses ha
93  alternative splicing of the tat/rev mRNA of equine infectious anemia virus (EIAV).
94 lowing infection of horses by the lentivirus equine infectious anemia virus (EIAV).
95 U3 region of a distantly related lentivirus, equine infectious anemia virus (EIAV).
96 enetic modification by the lentiviral vector equine infectious anemia virus (EIAV).
97 been identified as a functional receptor for equine infectious anemia virus (EIAV).
98  immunodeficiency virus, type 1 (HIV-1), and equine infectious anemia virus (EIAV).
99 planted into the heterologous Gag protein of equine infectious anemia virus (EIAV).
100 s of adeno-associated virus 2 (AAV2)/GDNF or equine infectious anemia virus (EIAV)/GDNF into the caud
101 human immunodeficiency virus type 1 [HIV-1], equine infectious anemia virus [EIAV]) and unrestricted
102 lentiviruses, including HIV-1 (but excluding equine infectious anemia virus), encode a viral infectiv
103                           The Rev protein of equine infectious anemia virus (ERev) exports unspliced
104 ilarity to the YPDL late domain found in the equine infectious anemia virus Gag protein.
105 vators (Tat) from human immunodeficiency and equine infectious anemia viruses (HIV and EIAV) interact
106                                              Equine infectious anemia virus is a lentivirus that repl
107 e association of Alix 364-716 with HIV-1 and equine infectious anemia virus late domains was quantita
108 t not by the 55-amino acid form (NC55) or by equine infectious anemia virus NC.
109 an immunodeficiency virus type 1 (HIV-1) and equine infectious anemia virus particle production.
110 -independent budding previously observed for equine infectious anemia virus (plasma membrane assembly
111 tical for control of lentiviruses, including equine infectious anemia virus, relatively little is kno
112  human T-cell leukemia virus type 1 Rex, and equine infectious anemia virus Rev but not with function
113 two nonprimate lentiviruses, visna virus and equine infectious anemia virus, revealed that their acti
114 s supported by the 66 and 51 kDa subunits of equine infectious anemia virus reverse transcriptase (EI
115 echanism underlying this event, catalyzed by equine infectious anemia virus reverse transcriptase (EI
116 molecules that present important epitopes to equine infectious anemia virus-specific CTL.
117 nstrated that pseudotyping of the nonprimate equine infectious anemia virus (using the lentivector ge
118 ed that a successful experimental attenuated equine infectious anemia virus vaccine, derived by mutat

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top